News

Neuroblastoma: Liquid biopsies to detect relapse of childhood cancer early (Vienna, 29.1.2024) Neuroblastoma mainly affects toddlers and young children – in the EU region there are 1500 new cases per year. Neuroblastoma is a malignant tumor of the peripheral nervous system and around 50% of patients are high-risk cases. Recurrences occur frequently, and conventional therapies are […]

CCRI – CeMM Collaboration Agreement (Vienna, 22.01.2024) CCRI Directors Kaan Boztug and Jörg Bürger, and CeMM Directors Giulio Superti-Furga and Anita Ender have signed a partnership agreement which further strengthens scientific collaborations and training aspects.  CeMM’s research is strongly oriented towards medical needs and integrates research on fundamental biological processes with clinical expertise to gain

“Don’t let obstacles deter you.”  (Vienna, 22.12.2023) Journalist Christian Rainer in a nutshell: what he would do if he were 16 years old again, how he deals with criticism and what he would like to change in the world, he told us in the “Reaching for the stars” interview! Under the motto of our 35th anniversary

Inaugural International Workshop on Innovative Models for Neuroblastoma Research (Vienna, 15.12.2023) On December 14th and 15th, the St. Anna Children’s Cancer Research Institute proudly hosted the inaugural International Workshop on Innovative Models for Neuroblastoma Research. This groundbreaking event gathered experts from Austria, the UK, the USA, Belgium, and Sweden, all converging at St. Anna CCRI

35 Years Anniversary Report Our anniversary report on the occasion of our 35th birthday is here! Under the motto “Reaching for the Stars“, embark on a journey through time of 35 Years St. Anna Children’s Cancer Research Institute, be inspired by exciting interviews with prominent supporters and get a detailed insight into our scientific milestones

35 Years of Pioneering Pediatric Cancer Research: An Anniversary Shaping the Future (Vienna, 05.12.2023) The St. Anna Children’s Cancer Research Institute celebrates 35 years at the forefront of scientific efforts against pediatric cancer. On this anniversary, the institute granted rare insights into its laboratories, showcasing the cutting-edge research that is conducted. Afterwards, the management presented

“Humor is always self-defense”  (Vienna, 29.11.2023) Comedian Aida Loos in a nutshell: She told us what humor means to her, what part of her job she values most and why she supports St. Anna Children’s Cancer Research Institute in our “Reaching for the Stars” interview! Under the motto of our 35th anniversary “Reaching for the stars”,

Joint Effort to Fast-Track Diagnoses (Vienna, 21.11.2023) Partners from two EU-funded initiatives, the European Joint Program for Rare Diseases (EJPRD) and The European Rare Diseases Research Coordination and Support Action (ERICA), converged at a joint conference in Amsterdam. The joint conference of EJPRD and ERICA served as a critical platform for participants to explore and

VULSK Specialists Immerse in Clinical Trials Training at St. Anna CCRI under TREL Project (Vienna, 17.11.2023) The EU-funded project TREL seeks to bridge gaps in research indicators and treatment outcomes by fostering collaboration, knowledge sharing, and skill development. This week, the St. Anna Childrens Cancer Research Institute warmly welcomed three specialists from Vilnius University Hospital Santaros Klinikos (VULSK)

“Being able to laugh at yourself is a personal way of living.”  (Vienna, 24.10.2023) Comedian and artist Josef Hader in a nutshell: What he likes best about his job, why he supports St. Anna Children’s Cancer Research Institute and what else he would like to be able to do. Under the motto of our 35th

3rd School of Malignant Lymphomas in Ljubljana (Vienna, 19.10.2023) The 3rd School of Malignant Lymphomas in Ljubljana recently concluded its first day, marking a significant milestone in the field of lymphoma research and diagnostics. The event featured contributions from St. Anna CCRI’s  scientists, Margarita Maurer-Granofszky and Anna-Maria Husa, who led insightful workshops focused on high-end

Network-based approaches open a new avenue to classify and treat rare diseases Scientists at CeMM, Max Perutz Labs, and St. Anna Children’s Cancer Research Institute have achieved a significant advancement in the research of rare immune system disorders. Through a network-based approach, they have reclassified approximately 200 rare diseases. Initial comparisons with clinical data already

Childhood Cancer Awareness Month 2023 (Vienna, 01.09.2023) Throughout the year, we are committed to raising awareness about childhood cancer, which fundamentally differs from adult cancer. Every September, during Childhood Cancer Awareness Month, we think of something special to go the extra mile. This year we interviewed our young cancer researchers, delving deeper into the personal

Gene Mutation in the Immune System: Anti-Diabetes Drugs Make Immune Cells More Effective Again (Vienna, 31.08.2023) T cells are an essential component of the immune system – they fight foreign structures such as bacteria and viruses or cancer-related changes in cells. This defense reaction requires energy. Scientists led by the St. Anna Children’s Cancer Research Institute